GMP Manufacturing Ltd is collaborating with the Satellite Applications Catapult to explore how space-enabled research and microgravity environments could support the future of pharmaceutical development, manufacturing and advanced therapeutic innovation.
Microgravity has long been recognised as a unique research environment, but its potential application in pharmaceutical science is now gaining increasing interest. By reducing the effects of gravity-driven sedimentation, buoyancy, and convection, microgravity may provide new ways to study biological systems, protein behaviour, cell responses, formulation stability, and manufacturing processes that are difficult to investigate on Earth.
Through this programme, GMP Manufacturing Ltd and the Satellite Applications Catapult are exploring commercially relevant opportunities where microgravity research could contribute to pharmaceutical R & D, including drug discovery, biologics, cell and gene therapies, precision medicine, advanced manufacturing and protein crystal growth.
The initiative aims to identify practical research questions where space-enabled experimentation may offer scientific or manufacturing advantages. This includes areas such as:
These opportunity areas align with GMP Manufacturing Ltd’s wider interest in future medicines, pharmaceutical innovation and applied research that can support real-world healthcare and manufacturing outcomes.
GMP Manufacturing Ltd sees microgravity not only as a space research environment, but as a potential platform for discovering new biology, advancing pharmaceutical science and accelerating the development of future medicines. The collaboration with the Satellite Applications Catapult provides an opportunity to connect pharmaceutical expertise with the UK’s growing space innovation ecosystem
By bringing together CDMO experience, pharmaceutical development knowledge and space-enabled innovation capabilities, the programme will explore how microgravity research can be translated into practical, commercially relevant opportunities for the pharmaceutical sector.
As part of the programme, GMP Manufacturing Ltd is interested in engaging with pharmaceutical companies, biotechnology organisations, academic researchers, CROs, CDMOs and innovation teams to identify research opportunities where microgravity may provide a meaningful scientific or manufacturing advantage.
The focus will be on opportunities that are not only scientifically interesting, but also commercially relevant, fundable and capable of attracting strategic partners. This includes identifying use cases that could lead to collaborative research projects, consortium development, funding proposals and future innovation programmes.
The collaboration reflects a broader opportunity for UK organisations to demonstrate leadership in translating space technologies into tangible healthcare and pharmaceutical innovation.
By exploring the intersection of microgravity research and pharmaceutical science, GMP Manufacturing Ltd and the Satellite Applications Catapult aim to help open new conversations across the pharmaceutical sector and support the development of next-generation research platforms.
GMP Manufacturing Ltd welcomes discussions with organisations interested in exploring how microgravity research could support future pharmaceutical R & D, advanced therapies, manufacturing innovation or precision medicine.
To discuss potential collaboration opportunities, please write to space@gmpcom.com